Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Feb;51(2):261–268.

Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes.

R P Kimberly, T M Parris, R D Inman, J S McDougal
PMCID: PMC1536877  PMID: 6839542

Abstract

Seventeen pairs of longitudinal studies of mononuclear phagocyte system (MPS) Fc receptor function in 15 patients with systemic lupus were performed to explore the dynamic range of Fc receptor dysfunction in lupus and to establish the relationships between MPS function, clinical disease activity and circulating immune complexes (CIC). Fc receptor function was measured by the clearance of IgG sensitized autologous erythrocytes. At the time of first study the degree of MPS dysfunction was correlated with both clinical activity (P less than 0.05) and CIC (P less than 0.05). At follow-up patients with a change in clinical status show significantly larger changes in clearance function compared to clinically stable patients (206 min vs 7 min; P less than 0.001). MPS function changed concordantly with a change in clinical status in all cases (P = 0.002). Longitudinal assessments did not demonstrate concordance of changes in MPS function and CIC, measured by three different assays. The MPS Fc receptor defect in systemic lupus is dynamic and closely associated with disease activity. The lack of concordance of the defect with changes in CIC suggests that either CIC does not adequately reflect receptor site saturation or that other factors may also contribute to the magnitude of MPS dysfunction.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C. L., Stillman W. S. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. J Clin Invest. 1980 Aug;66(2):353–360. doi: 10.1172/JCI109863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arend W. P., Emmerich T. E., Sturge J. C., Starkebaum G. A. Monocyte-reactive antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1977 Jun;20(5):1049–1057. doi: 10.1002/art.1780200503. [DOI] [PubMed] [Google Scholar]
  3. Barcelli U., Rademacher R., Ooi Y. M., Ooi B. S. Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system. J Clin Invest. 1981 Jan;67(1):20–27. doi: 10.1172/JCI110013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Couser W. G., Steinmuller D. R., Stilmant M. M., Salant D. J., Lowenstein L. M. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest. 1978 Dec;62(6):1275–1287. doi: 10.1172/JCI109248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fleuren G., Grond J., Hoedemaeker P. J. In situ formation of subepithelial glomerular immune complexes in passive serum sickness. Kidney Int. 1980 May;17(5):631–637. doi: 10.1038/ki.1980.74. [DOI] [PubMed] [Google Scholar]
  6. Ford P. M., Kosatka I. In situ formation of antigen-antibody complexes in the mouse glomerulus. Immunology. 1979 Nov;38(3):473–479. [PMC free article] [PubMed] [Google Scholar]
  7. Frank M. M., Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med. 1979 Mar 8;300(10):518–523. doi: 10.1056/NEJM197903083001002. [DOI] [PubMed] [Google Scholar]
  8. Griffin F. M., Jr Effects of soluble immune complexes on Fc receptor- and C3b receptor-mediated phagocytosis by macrophages. J Exp Med. 1980 Oct 1;152(4):905–919. doi: 10.1084/jem.152.4.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haakenstad A. O., Case J. B., Mannik M. Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes. J Immunol. 1975 Apr;114(4):1153–1160. [PubMed] [Google Scholar]
  10. Haakenstad A. O., Mannik M. Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol. 1974 May;112(5):1939–1948. [PubMed] [Google Scholar]
  11. Haakenstad A. O., Striker G. E., Mannik M. The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest. 1976 Sep;35(3):293–301. [PubMed] [Google Scholar]
  12. Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H., Frank M. M. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. Arthritis Rheum. 1982 Jan;25(1):48–54. doi: 10.1002/art.1780250108. [DOI] [PubMed] [Google Scholar]
  13. Hamburger M. I., Moutsopoulos H. M., Lawley T. J., Frank M. M. Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance. Ann Intern Med. 1979 Oct;91(4):534–538. doi: 10.7326/0003-4819-91-4-534. [DOI] [PubMed] [Google Scholar]
  14. Horsfall A. C., Venables P. J., Mumford P. A., Maini R. N. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes. Clin Exp Immunol. 1981 May;44(2):405–415. [PMC free article] [PubMed] [Google Scholar]
  15. KENT J. F., FIFE E. H., Jr Precise standardization of reagents for complement fixation. Am J Trop Med Hyg. 1963 Jan;12:103–116. doi: 10.4269/ajtmh.1963.12.103. [DOI] [PubMed] [Google Scholar]
  16. Kurlander R. J. Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G. J Clin Invest. 1980 Oct;66(4):773–781. doi: 10.1172/JCI109915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lawley T. J., Hall R. P., Fauci A. S., Katz S. I., Hamburger M. I., Frank M. M. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. N Engl J Med. 1981 Jan 22;304(4):185–192. doi: 10.1056/NEJM198101223040401. [DOI] [PubMed] [Google Scholar]
  18. McDougal J. S., Redecha P. B., Inman R. D., Christian C. L. Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A. J Clin Invest. 1979 Apr;63(4):627–636. doi: 10.1172/JCI109345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Parris T. M., Kimberly R. P., Inman R. D., McDougal J. S., Gibofsky A., Christian C. L. Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann Intern Med. 1982 Oct;97(4):526–532. doi: 10.7326/0003-4819-97-4-526. [DOI] [PubMed] [Google Scholar]
  20. Pearson L., Lightfoot R. W., Jr Correlation of DNA-anti-DNA association rates with clinical activity in systemic lupus erythematosus (SLE). J Immunol. 1981 Jan;126(1):16–19. [PubMed] [Google Scholar]
  21. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  22. ROTHFIELD N. F., PACE N. Relation of positive L.E.-cell preparations to activity of lupus erythematosus and corticosteroid therapy. N Engl J Med. 1962 Mar 15;266:535–538. doi: 10.1056/NEJM196203152661103. [DOI] [PubMed] [Google Scholar]
  23. Rabinovitch M., Manejias R. E., Nussenzweig V. Selective phagocytic paralysis induced by immobilized immune complexes. J Exp Med. 1975 Oct 1;142(4):827–838. doi: 10.1084/jem.142.4.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ragsdale C. G., Arend W. P. Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotides. J Exp Med. 1980 Jan 1;151(1):32–44. doi: 10.1084/jem.151.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Raij L., Sibley R. K., Keane W. F. Mononuclear phagocytic system stimulation. Protective role from glomerular immune complex deposition. J Lab Clin Med. 1981 Oct;98(4):558–567. [PubMed] [Google Scholar]
  26. Svensson B. O. Serum factors causing impaired macrophage function in systemic lupus erythematosus. Scand J Immunol. 1975;4(2):145–150. doi: 10.1111/j.1365-3083.1975.tb02611.x. [DOI] [PubMed] [Google Scholar]
  27. Theofilopoulos A. N., Wilson C. B., Dixon F. J. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest. 1976 Jan;57(1):169–182. doi: 10.1172/JCI108257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Williams R. C., Jr Immune complexes: a clinical perspective. Am J Med. 1981 Nov;71(5):743–745. doi: 10.1016/0002-9343(81)90352-1. [DOI] [PubMed] [Google Scholar]
  29. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES